Full name
ADVANCED CLINICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
ADVANCED CLINICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. MARSZAŁKOWSKA 126/134, 00-008 WARSZAWA
TAX ID5252834948
Rate company:
ADVANCED CLINICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5252834948
KRS0000851790
Share capital5,000.00 zł
address
UL. MARSZAŁKOWSKA 126/134, 00-008 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5252834948
REGON
386977454
KRS
0000851790
Legal form
limited liability company
Register Address
UL. MARSZAŁKOWSKA 126/134, 00-008 WARSZAWA
Date of registration in KRS
2020-09-08
Date of commencement of economic activity
2020-09-08
Act signature
RDF/607877/24/988
Pkd codes
72.19.Z - Other research and experimental development on natural sciences and engineering
70 - Activities of head offices; management consultancy activities
71.20 - Technical testing and analysis
72 - Scientific research and development
73.20 - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82 - Office administrative, office support and other business support activities
Payer VAT status
Active
Vat list bank account(s)
PL27 1600 1462 1891 0299 6000 0001 
PL97 1600 1462 1891 0299 6000 0002 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets  | 0,2 | 0,4 | 0,8 | 84,3 |
Gross profit (loss) | 0 | 0,1 | 0,2 | 145,1 |
Net profit (loss) | 0 | 0,1 | 0,1 | 155,9 |
Cash | 0,1 | 0 | 0,1 | 6225,7 |
Liabilities and provisions for liabilities | 0,1 | 0,4 | 0,6 | 63,4 |
Net income from sale | 0,5 | 1,5 | 3,8 | 163 |
Short time liabilities | 0,1 | 0,2 | 0,3 | 21,9 |
Working assets | 0,2 | 0,4 | 0,8 | 84,3 |
Equity capital | 0 | 0,1 | 0,2 | 173,8 |
Operating profit (EBIT) | 0 | 0,1 | 0,2 | 163 |
% | % | % | p.p. | |
Profitability of capital | 81,3 | 67,9 | 63,5 | -4,4 |
Equity capital to total assets | 16,5 | 19 | 28,2 | 9,2 |
Gross profit margin | 7,4 | 5 | 4,6 | -0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 64 | 53 | 24 | -29 |
Financial statements
01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xades01-01-2023 - 31-12-2023
Annual financial report
Download pdfuses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.